Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) Stock Competitors & Peer Comparison
See JAGLX's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Asset Management - Global Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for JAGLX and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| JAGLX | $89.48 | -1.12% | 6B | N/A | N/A | N/A |
| VTI | $382.45 | -0.48% | 2.3T | 27.34 | $14.04 | +1.02% |
| IVV | $777.03 | -0.57% | 903.9B | 28.06 | $27.80 | +1.05% |
| VXUS | $87.85 | +0.15% | 674.1B | 18.40 | $4.77 | +2.50% |
| VWO | $60.35 | +0.02% | 167.8B | 16.97 | $3.54 | +2.30% |
| IEMG | $82.03 | +0.91% | 166.1B | 17.60 | $4.61 | +2.22% |
| SPYM | $91.04 | -0.57% | 161.4B | 27.80 | $3.29 | +1.00% |
| IWF | $125.22 | -0.35% | 136.5B | 32.82 | $3.82 | +0.34% |
| VT | $161.90 | -0.30% | 100.7B | 23.16 | $7.00 | +1.53% |
| RSP | $221.31 | -0.64% | 100.2B | 24.10 | $9.24 | +1.44% |
Stock Comparison
Vanguard Morningstar Total Stock Market ETF (AMEX: VTI)
JAGLX vs VTI Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, VTI has a market cap of 2.3T. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while VTI trades at $382.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VTI's P/E ratio is 27.34. In terms of profitability, JAGLX's ROE is N/A, compared to VTI's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VTI. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VTI's competition here
iShares Core S&P 500 ETF (AMEX: IVV)
JAGLX vs IVV Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IVV has a market cap of 903.9B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IVV trades at $777.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IVV's P/E ratio is 28.06. In terms of profitability, JAGLX's ROE is N/A, compared to IVV's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IVV. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IVV's competition here
Vanguard Total International Stock ETF (NASDAQ: VXUS)
JAGLX vs VXUS Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, VXUS has a market cap of 674.1B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while VXUS trades at $87.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VXUS's P/E ratio is 18.40. In terms of profitability, JAGLX's ROE is N/A, compared to VXUS's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VXUS. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VXUS's competition here
Vanguard FTSE Emerging Markets ETF (AMEX: VWO)
JAGLX vs VWO Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, VWO has a market cap of 167.8B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while VWO trades at $60.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VWO's P/E ratio is 16.97. In terms of profitability, JAGLX's ROE is N/A, compared to VWO's ROE of N/A. Regarding short-term risk, JAGLX is less volatile compared to VWO. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VWO's competition here
iShares Core MSCI Emerging Markets ETF (AMEX: IEMG)
JAGLX vs IEMG Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IEMG has a market cap of 166.1B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IEMG trades at $82.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IEMG's P/E ratio is 17.60. In terms of profitability, JAGLX's ROE is N/A, compared to IEMG's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IEMG. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IEMG's competition here
State Street SPDR Portfolio S&P 500 ETF (AMEX: SPYM)
JAGLX vs SPYM Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, SPYM has a market cap of 161.4B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while SPYM trades at $91.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SPYM's P/E ratio is 27.80. In terms of profitability, JAGLX's ROE is N/A, compared to SPYM's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to SPYM. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check SPYM's competition here
iShares Russell 1000 Growth ETF (AMEX: IWF)
JAGLX vs IWF Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IWF has a market cap of 136.5B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IWF trades at $125.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWF's P/E ratio is 32.82. In terms of profitability, JAGLX's ROE is N/A, compared to IWF's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IWF. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IWF's competition here
Vanguard Total World Stock ETF (AMEX: VT)
JAGLX vs VT Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, VT has a market cap of 100.7B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while VT trades at $161.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VT's P/E ratio is 23.16. In terms of profitability, JAGLX's ROE is N/A, compared to VT's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VT. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VT's competition here
Invesco S&P 500 Equal Weight ETF (AMEX: RSP)
JAGLX vs RSP Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, RSP has a market cap of 100.2B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while RSP trades at $221.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas RSP's P/E ratio is 24.10. In terms of profitability, JAGLX's ROE is N/A, compared to RSP's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to RSP. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check RSP's competition here
Vanguard FTSE All-World ex-US ETF (AMEX: VEU)
JAGLX vs VEU Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, VEU has a market cap of 97.6B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while VEU trades at $85.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VEU's P/E ratio is 18.51. In terms of profitability, JAGLX's ROE is N/A, compared to VEU's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VEU. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VEU's competition here
iShares Russell 1000 Value ETF (AMEX: IWD)
JAGLX vs IWD Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IWD has a market cap of 81.1B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IWD trades at $256.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWD's P/E ratio is 24.07. In terms of profitability, JAGLX's ROE is N/A, compared to IWD's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IWD. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IWD's competition here
iShares MSCI EAFE ETF (AMEX: EFA)
JAGLX vs EFA Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, EFA has a market cap of 79.1B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while EFA trades at $108.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas EFA's P/E ratio is 19.30. In terms of profitability, JAGLX's ROE is N/A, compared to EFA's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to EFA. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check EFA's competition here
iShares S&P 500 Growth ETF (AMEX: IVW)
JAGLX vs IVW Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IVW has a market cap of 77.5B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IVW trades at $141.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IVW's P/E ratio is 788.78. In terms of profitability, JAGLX's ROE is N/A, compared to IVW's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IVW. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IVW's competition here
First Eagle Global Fund (NASDAQ: SGENX)
JAGLX vs SGENX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, SGENX has a market cap of 74.8B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while SGENX trades at $89.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SGENX's P/E ratio is 18.80. In terms of profitability, JAGLX's ROE is N/A, compared to SGENX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to SGENX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check SGENX's competition here
Schwab International Equity ETF (AMEX: SCHF)
JAGLX vs SCHF Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, SCHF has a market cap of 68.4B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while SCHF trades at $28.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SCHF's P/E ratio is 19.25. In terms of profitability, JAGLX's ROE is N/A, compared to SCHF's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to SCHF. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check SCHF's competition here
iShares Core MSCI Total International Stock ETF (NASDAQ: IXUS)
JAGLX vs IXUS Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IXUS has a market cap of 60.3B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IXUS trades at $98.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IXUS's P/E ratio is 18.57. In terms of profitability, JAGLX's ROE is N/A, compared to IXUS's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IXUS. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IXUS's competition here
iShares Russell Mid-Cap ETF (AMEX: IWR)
JAGLX vs IWR Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IWR has a market cap of 58.9B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IWR trades at $114.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWR's P/E ratio is 24.29. In terms of profitability, JAGLX's ROE is N/A, compared to IWR's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IWR. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IWR's competition here
Vanguard Russell 1000 Growth ETF (NASDAQ: VONG)
JAGLX vs VONG Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, VONG has a market cap of 56.5B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while VONG trades at $128.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VONG's P/E ratio is 32.79. In terms of profitability, JAGLX's ROE is N/A, compared to VONG's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VONG. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VONG's competition here
iShares S&P 500 Value ETF (AMEX: IVE)
JAGLX vs IVE Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IVE has a market cap of 50.3B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IVE trades at $236.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IVE's P/E ratio is 24.69. In terms of profitability, JAGLX's ROE is N/A, compared to IVE's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IVE. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IVE's competition here
iShares Russell 1000 ETF (AMEX: IWB)
JAGLX vs IWB Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IWB has a market cap of 49.6B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IWB trades at $423.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWB's P/E ratio is 27.68. In terms of profitability, JAGLX's ROE is N/A, compared to IWB's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IWB. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IWB's competition here
State Street SPDR Portfolio Developed World ex-US ETF (AMEX: SPDW)
JAGLX vs SPDW Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, SPDW has a market cap of 41.8B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while SPDW trades at $52.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SPDW's P/E ratio is 19.00. In terms of profitability, JAGLX's ROE is N/A, compared to SPDW's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to SPDW. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check SPDW's competition here
Vanguard FTSE Europe ETF (AMEX: VGK)
JAGLX vs VGK Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, VGK has a market cap of 38.6B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while VGK trades at $92.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VGK's P/E ratio is 18.59. In terms of profitability, JAGLX's ROE is N/A, compared to VGK's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VGK. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VGK's competition here
State Street SPDR Portfolio S&P 500 Value ETF (AMEX: SPYV)
JAGLX vs SPYV Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, SPYV has a market cap of 37.2B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while SPYV trades at $63.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SPYV's P/E ratio is 23.98. In terms of profitability, JAGLX's ROE is N/A, compared to SPYV's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to SPYV. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check SPYV's competition here
American Funds Global Balanced Fd Cl F-1 (NASDAQ: GBLEX)
JAGLX vs GBLEX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, GBLEX has a market cap of 33.3B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while GBLEX trades at $43.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas GBLEX's P/E ratio is 22.18. In terms of profitability, JAGLX's ROE is N/A, compared to GBLEX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to GBLEX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check GBLEX's competition here
iShares MSCI Emerging Markets ETF (AMEX: EEM)
JAGLX vs EEM Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, EEM has a market cap of 31.2B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while EEM trades at $67.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas EEM's P/E ratio is 17.64. In terms of profitability, JAGLX's ROE is N/A, compared to EEM's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to EEM. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check EEM's competition here
State Street SPDR S&P MIDCAP 400 ETF Trust (AMEX: MDY)
JAGLX vs MDY Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, MDY has a market cap of 29.3B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while MDY trades at $715.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas MDY's P/E ratio is 22.92. In terms of profitability, JAGLX's ROE is N/A, compared to MDY's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to MDY. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check MDY's competition here
Vanguard S&P 500 Growth ETF (AMEX: VOOG)
JAGLX vs VOOG Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, VOOG has a market cap of 27.6B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while VOOG trades at $85.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VOOG's P/E ratio is 31.96. In terms of profitability, JAGLX's ROE is N/A, compared to VOOG's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VOOG. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VOOG's competition here
Avantis Emerging Markets Equity ETF (AMEX: AVEM)
JAGLX vs AVEM Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, AVEM has a market cap of 27.4B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while AVEM trades at $94.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas AVEM's P/E ratio is 15.26. In terms of profitability, JAGLX's ROE is N/A, compared to AVEM's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to AVEM. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check AVEM's competition here
iShares MSCI Emerging Markets ex China ETF (NASDAQ: EMXC)
JAGLX vs EMXC Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, EMXC has a market cap of 27.2B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while EMXC trades at $98.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas EMXC's P/E ratio is 19.41. In terms of profitability, JAGLX's ROE is N/A, compared to EMXC's ROE of N/A. Regarding short-term risk, JAGLX is less volatile compared to EMXC. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check EMXC's competition here
Schwab Fundamental International Large Company Index ETF (AMEX: FNDF)
JAGLX vs FNDF Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, FNDF has a market cap of 24.6B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while FNDF trades at $55.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas FNDF's P/E ratio is 17.55. In terms of profitability, JAGLX's ROE is N/A, compared to FNDF's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to FNDF. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check FNDF's competition here
iShares MSCI Japan ETF (AMEX: EWJ)
JAGLX vs EWJ Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, EWJ has a market cap of 23.2B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while EWJ trades at $98.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas EWJ's P/E ratio is 20.18. In terms of profitability, JAGLX's ROE is N/A, compared to EWJ's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to EWJ. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check EWJ's competition here
Vanguard Russell 1000 Value ETF (NASDAQ: VONV)
JAGLX vs VONV Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, VONV has a market cap of 22B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while VONV trades at $112.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VONV's P/E ratio is 23.81. In terms of profitability, JAGLX's ROE is N/A, compared to VONV's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VONV. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VONV's competition here
American Funds Global Insight Fund Class F-1 (NASDAQ: AGVEX)
JAGLX vs AGVEX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, AGVEX has a market cap of 21.8B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while AGVEX trades at $32.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas AGVEX's P/E ratio is 28.41. In terms of profitability, JAGLX's ROE is N/A, compared to AGVEX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to AGVEX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check AGVEX's competition here
iShares Russell Mid-Cap Growth ETF (AMEX: IWP)
JAGLX vs IWP Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IWP has a market cap of 21.2B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IWP trades at $148.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWP's P/E ratio is 32.94. In terms of profitability, JAGLX's ROE is N/A, compared to IWP's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IWP. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IWP's competition here
Invesco S&P 500 Quality ETF (AMEX: SPHQ)
JAGLX vs SPHQ Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, SPHQ has a market cap of 20.9B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while SPHQ trades at $87.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SPHQ's P/E ratio is 28.52. In terms of profitability, JAGLX's ROE is N/A, compared to SPHQ's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to SPHQ. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check SPHQ's competition here
Dimensional - International Value ETF (AMEX: DFIV)
JAGLX vs DFIV Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, DFIV has a market cap of 20.1B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while DFIV trades at $58.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas DFIV's P/E ratio is 15.78. In terms of profitability, JAGLX's ROE is N/A, compared to DFIV's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to DFIV. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check DFIV's competition here
Avantis International Small Cap Value ETF (AMEX: AVDV)
JAGLX vs AVDV Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, AVDV has a market cap of 20B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while AVDV trades at $111.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas AVDV's P/E ratio is 14.12. In terms of profitability, JAGLX's ROE is N/A, compared to AVDV's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to AVDV. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check AVDV's competition here
iShares Russell 3000 ETF (AMEX: IWV)
JAGLX vs IWV Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IWV has a market cap of 20B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IWV trades at $440.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWV's P/E ratio is 27.38. In terms of profitability, JAGLX's ROE is N/A, compared to IWV's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IWV. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IWV's competition here
iShares ESG Aware MSCI USA ETF (NASDAQ: ESGU)
JAGLX vs ESGU Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, ESGU has a market cap of 18.2B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while ESGU trades at $169.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas ESGU's P/E ratio is 28.06. In terms of profitability, JAGLX's ROE is N/A, compared to ESGU's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to ESGU. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check ESGU's competition here
State Street SPDR Portfolio Emerging Markets ETF (AMEX: SPEM)
JAGLX vs SPEM Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, SPEM has a market cap of 17.7B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while SPEM trades at $52.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SPEM's P/E ratio is 16.74. In terms of profitability, JAGLX's ROE is N/A, compared to SPEM's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to SPEM. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check SPEM's competition here
Fidelity MSCI Information Technology Index ETF (AMEX: FTEC)
JAGLX vs FTEC Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, FTEC has a market cap of 17.6B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while FTEC trades at $292.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas FTEC's P/E ratio is 34.56. In terms of profitability, JAGLX's ROE is N/A, compared to FTEC's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to FTEC. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check FTEC's competition here
Dimensional - International Core Equity Market ETF (AMEX: DFAI)
JAGLX vs DFAI Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, DFAI has a market cap of 17.4B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while DFAI trades at $43.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas DFAI's P/E ratio is 18.91. In terms of profitability, JAGLX's ROE is N/A, compared to DFAI's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to DFAI. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check DFAI's competition here
iShares Russell Mid-Cap Value ETF (AMEX: IWS)
JAGLX vs IWS Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IWS has a market cap of 16.1B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IWS trades at $172.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWS's P/E ratio is 22.74. In terms of profitability, JAGLX's ROE is N/A, compared to IWS's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IWS. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IWS's competition here
Invesco S&P 500 Momentum ETF (AMEX: SPMO)
JAGLX vs SPMO Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, SPMO has a market cap of 15.9B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while SPMO trades at $155.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SPMO's P/E ratio is 32.61. In terms of profitability, JAGLX's ROE is N/A, compared to SPMO's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to SPMO. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check SPMO's competition here
iShares Russell 2000 Growth ETF (AMEX: IWO)
JAGLX vs IWO Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IWO has a market cap of 15.2B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IWO trades at $393.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWO's P/E ratio is 25.41. In terms of profitability, JAGLX's ROE is N/A, compared to IWO's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IWO. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IWO's competition here
Vanguard FTSE All-World ex-US Small-Cap ETF (AMEX: VSS)
JAGLX vs VSS Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, VSS has a market cap of 14.7B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while VSS trades at $160.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VSS's P/E ratio is 16.83. In terms of profitability, JAGLX's ROE is N/A, compared to VSS's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VSS. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VSS's competition here
iShares Russell 2000 Value ETF (AMEX: IWN)
JAGLX vs IWN Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IWN has a market cap of 14.7B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IWN trades at $225.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IWN's P/E ratio is 17.01. In terms of profitability, JAGLX's ROE is N/A, compared to IWN's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IWN. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IWN's competition here
Vanguard FTSE Pacific ETF (AMEX: VPL)
JAGLX vs VPL Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, VPL has a market cap of 14.6B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while VPL trades at $117.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VPL's P/E ratio is 18.85. In terms of profitability, JAGLX's ROE is N/A, compared to VPL's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VPL. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VPL's competition here
iShares MSCI Intl Quality Factor ETF (AMEX: IQLT)
JAGLX vs IQLT Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IQLT has a market cap of 14B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IQLT trades at $51.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IQLT's P/E ratio is 20.51. In terms of profitability, JAGLX's ROE is N/A, compared to IQLT's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IQLT. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IQLT's competition here
iShares MSCI EAFE Small-Cap ETF (NASDAQ: SCZ)
JAGLX vs SCZ Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, SCZ has a market cap of 13.7B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while SCZ trades at $86.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SCZ's P/E ratio is 16.15. In terms of profitability, JAGLX's ROE is N/A, compared to SCZ's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to SCZ. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check SCZ's competition here
iShares MSCI South Korea ETF (AMEX: EWY)
JAGLX vs EWY Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, EWY has a market cap of 13.6B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while EWY trades at $185.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas EWY's P/E ratio is 102.68. In terms of profitability, JAGLX's ROE is N/A, compared to EWY's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to EWY. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check EWY's competition here
Schwab Emerging Markets Equity ETF (AMEX: SCHE)
JAGLX vs SCHE Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, SCHE has a market cap of 12.7B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while SCHE trades at $36.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SCHE's P/E ratio is 17.09. In terms of profitability, JAGLX's ROE is N/A, compared to SCHE's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to SCHE. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check SCHE's competition here
Lazard Global Listed Infrastructure Portfolio Open Shares (NASDAQ: GLFOX)
JAGLX vs GLFOX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, GLFOX has a market cap of 12.4B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while GLFOX trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas GLFOX's P/E ratio is 19.92. In terms of profitability, JAGLX's ROE is N/A, compared to GLFOX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to GLFOX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check GLFOX's competition here
Capital Group Global Growth Equity ETF (AMEX: CGGO)
JAGLX vs CGGO Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, CGGO has a market cap of 12.4B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while CGGO trades at $41.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas CGGO's P/E ratio is 23.02. In terms of profitability, JAGLX's ROE is N/A, compared to CGGO's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to CGGO. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check CGGO's competition here
Lazard Global Listed Infrastructure Portfolio Institutional Shares (NASDAQ: GLIFX)
JAGLX vs GLIFX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, GLIFX has a market cap of 12.4B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while GLIFX trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas GLIFX's P/E ratio is 19.92. In terms of profitability, JAGLX's ROE is N/A, compared to GLIFX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to GLIFX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check GLIFX's competition here
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund (NASDAQ: GRID)
JAGLX vs GRID Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, GRID has a market cap of 12.3B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while GRID trades at $189.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas GRID's P/E ratio is 31.20. In terms of profitability, JAGLX's ROE is N/A, compared to GRID's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to GRID. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check GRID's competition here
iShares ESG Aware MSCI EAFE ETF (NASDAQ: ESGD)
JAGLX vs ESGD Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, ESGD has a market cap of 12.1B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while ESGD trades at $107.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas ESGD's P/E ratio is 19.76. In terms of profitability, JAGLX's ROE is N/A, compared to ESGD's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to ESGD. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check ESGD's competition here
Janus Henderson Global Technology and Innovation Fund T Shares (NASDAQ: JAGTX)
JAGLX vs JAGTX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, JAGTX has a market cap of 12B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while JAGTX trades at $87.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JAGTX's P/E ratio is N/A. In terms of profitability, JAGLX's ROE is N/A, compared to JAGTX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to JAGTX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check JAGTX's competition here
Janus Henderson Global Technology and Innovation Fund Class A (NASDAQ: JATAX)
JAGLX vs JATAX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, JATAX has a market cap of 12B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while JATAX trades at $84.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JATAX's P/E ratio is N/A. In terms of profitability, JAGLX's ROE is N/A, compared to JATAX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to JATAX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check JATAX's competition here
Janus Henderson Global Technology and Innovation Fund Class C (NASDAQ: JAGCX)
JAGLX vs JAGCX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, JAGCX has a market cap of 12B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while JAGCX trades at $65.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JAGCX's P/E ratio is N/A. In terms of profitability, JAGLX's ROE is N/A, compared to JAGCX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to JAGCX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check JAGCX's competition here
Vanguard Russell 1000 ETF (NASDAQ: VONE)
JAGLX vs VONE Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, VONE has a market cap of 11.9B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while VONE trades at $350.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VONE's P/E ratio is 27.51. In terms of profitability, JAGLX's ROE is N/A, compared to VONE's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VONE. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VONE's competition here
iShares MSCI ACWI ex U.S. ETF (NASDAQ: ACWX)
JAGLX vs ACWX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, ACWX has a market cap of 11.9B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while ACWX trades at $78.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas ACWX's P/E ratio is 18.86. In terms of profitability, JAGLX's ROE is N/A, compared to ACWX's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to ACWX. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check ACWX's competition here
Janus Henderson Global Technology and Innovation Fund (NASDAQ: JATSX)
JAGLX vs JATSX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, JATSX has a market cap of 11.9B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while JATSX trades at $80.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JATSX's P/E ratio is N/A. In terms of profitability, JAGLX's ROE is N/A, compared to JATSX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to JATSX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check JATSX's competition here
JPMorgan International Research Enhanced Equity ETF (AMEX: JIRE)
JAGLX vs JIRE Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, JIRE has a market cap of 11.4B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while JIRE trades at $85.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JIRE's P/E ratio is 19.17. In terms of profitability, JAGLX's ROE is N/A, compared to JIRE's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to JIRE. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check JIRE's competition here
Fidelity Nasdaq Composite Index ETF (NASDAQ: ONEQ)
JAGLX vs ONEQ Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, ONEQ has a market cap of 11.3B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while ONEQ trades at $104.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas ONEQ's P/E ratio is 31.00. In terms of profitability, JAGLX's ROE is N/A, compared to ONEQ's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to ONEQ. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check ONEQ's competition here
Global X - Artificial Intelligence & Technology ETF (NASDAQ: AIQ)
JAGLX vs AIQ Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, AIQ has a market cap of 11.2B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while AIQ trades at $64.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas AIQ's P/E ratio is 27.81. In terms of profitability, JAGLX's ROE is N/A, compared to AIQ's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to AIQ. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check AIQ's competition here
Fidelity Enhanced International ETF (AMEX: FENI)
JAGLX vs FENI Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, FENI has a market cap of 11.1B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while FENI trades at $41.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas FENI's P/E ratio is 17.71. In terms of profitability, JAGLX's ROE is N/A, compared to FENI's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to FENI. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check FENI's competition here
First Trust Nasdaq Cybersecurity ETF (NASDAQ: CIBR)
JAGLX vs CIBR Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, CIBR has a market cap of 10.8B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while CIBR trades at $98.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas CIBR's P/E ratio is 37.36. In terms of profitability, JAGLX's ROE is N/A, compared to CIBR's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to CIBR. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check CIBR's competition here
iShares Global Infrastructure ETF (NASDAQ: IGF)
JAGLX vs IGF Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IGF has a market cap of 10.7B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IGF trades at $65.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IGF's P/E ratio is 21.96. In terms of profitability, JAGLX's ROE is N/A, compared to IGF's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IGF. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IGF's competition here
ClearBridge Large Cap Growth IS (NASDAQ: LSITX)
JAGLX vs LSITX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, LSITX has a market cap of 10.5B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while LSITX trades at $78.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas LSITX's P/E ratio is 33.23. In terms of profitability, JAGLX's ROE is N/A, compared to LSITX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to LSITX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check LSITX's competition here
Invesco S&P 500 Top 50 ETF (AMEX: XLG)
JAGLX vs XLG Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, XLG has a market cap of 10.5B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while XLG trades at $62.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas XLG's P/E ratio is 28.90. In terms of profitability, JAGLX's ROE is N/A, compared to XLG's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to XLG. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check XLG's competition here
Schwab Fundamental U.S. Small Company Index ETF (AMEX: FNDA)
JAGLX vs FNDA Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, FNDA has a market cap of 9.7B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while FNDA trades at $38.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas FNDA's P/E ratio is 20.77. In terms of profitability, JAGLX's ROE is N/A, compared to FNDA's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to FNDA. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check FNDA's competition here
Dimensional - Emerging Markets Core Equity 2 ETF (AMEX: DFEM)
JAGLX vs DFEM Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, DFEM has a market cap of 9.7B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while DFEM trades at $40.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas DFEM's P/E ratio is 16.85. In terms of profitability, JAGLX's ROE is N/A, compared to DFEM's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to DFEM. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check DFEM's competition here
Invesco S&P 500 Revenue ETF (AMEX: RWL)
JAGLX vs RWL Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, RWL has a market cap of 9.4B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while RWL trades at $134.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas RWL's P/E ratio is 20.71. In terms of profitability, JAGLX's ROE is N/A, compared to RWL's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to RWL. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check RWL's competition here
Xtrackers MSCI EAFE Hedged Equity ETF (AMEX: DBEF)
JAGLX vs DBEF Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, DBEF has a market cap of 9.3B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while DBEF trades at $56.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas DBEF's P/E ratio is 19.83. In terms of profitability, JAGLX's ROE is N/A, compared to DBEF's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to DBEF. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check DBEF's competition here
Schwab Fundamental Emerging Markets Large Company Index ETF (AMEX: FNDE)
JAGLX vs FNDE Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, FNDE has a market cap of 9.2B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while FNDE trades at $41.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas FNDE's P/E ratio is 12.51. In terms of profitability, JAGLX's ROE is N/A, compared to FNDE's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to FNDE. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check FNDE's competition here
iShares Global Tech ETF (AMEX: IXN)
JAGLX vs IXN Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IXN has a market cap of 9B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IXN trades at $144.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IXN's P/E ratio is 33.25. In terms of profitability, JAGLX's ROE is N/A, compared to IXN's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IXN. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IXN's competition here
Invesco S&P MidCap Momentum ETF (AMEX: XMMO)
JAGLX vs XMMO Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, XMMO has a market cap of 8.5B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while XMMO trades at $166.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas XMMO's P/E ratio is 30.60. In terms of profitability, JAGLX's ROE is N/A, compared to XMMO's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to XMMO. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check XMMO's competition here
VictoryShares Free Cash Flow ETF (NASDAQ: VFLO)
JAGLX vs VFLO Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, VFLO has a market cap of 8.4B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while VFLO trades at $53.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VFLO's P/E ratio is 22.01. In terms of profitability, JAGLX's ROE is N/A, compared to VFLO's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VFLO. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VFLO's competition here
American Funds Global Growth Portfolio Class F-1 (NASDAQ: PGGFX)
JAGLX vs PGGFX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, PGGFX has a market cap of 8.3B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while PGGFX trades at $30.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas PGGFX's P/E ratio is 26.84. In terms of profitability, JAGLX's ROE is N/A, compared to PGGFX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to PGGFX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check PGGFX's competition here
iShares MSCI World ETF (AMEX: URTH)
JAGLX vs URTH Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, URTH has a market cap of 8.3B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while URTH trades at $210.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas URTH's P/E ratio is 25.10. In terms of profitability, JAGLX's ROE is N/A, compared to URTH's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to URTH. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check URTH's competition here
Vanguard Global Equity Fund (NASDAQ: VHGEX)
JAGLX vs VHGEX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, VHGEX has a market cap of 7.7B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while VHGEX trades at $42.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VHGEX's P/E ratio is 24.02. In terms of profitability, JAGLX's ROE is N/A, compared to VHGEX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to VHGEX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check VHGEX's competition here
DFA Global Real Estate Securities Port (NASDAQ: DFGEX)
JAGLX vs DFGEX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, DFGEX has a market cap of 7.5B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while DFGEX trades at $11.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas DFGEX's P/E ratio is N/A. In terms of profitability, JAGLX's ROE is N/A, compared to DFGEX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to DFGEX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check DFGEX's competition here
WisdomTree Japan Hedged Equity Fund (AMEX: DXJ)
JAGLX vs DXJ Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, DXJ has a market cap of 7.4B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while DXJ trades at $181.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas DXJ's P/E ratio is 18.44. In terms of profitability, JAGLX's ROE is N/A, compared to DXJ's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to DXJ. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check DXJ's competition here
JPMorgan Global Select Equity ETF (NASDAQ: JGLO)
JAGLX vs JGLO Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, JGLO has a market cap of 7.1B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while JGLO trades at $74.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JGLO's P/E ratio is 25.06. In terms of profitability, JAGLX's ROE is N/A, compared to JGLO's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to JGLO. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check JGLO's competition here
iShares ESG Aware MSCI EM ETF (NASDAQ: ESGE)
JAGLX vs ESGE Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, ESGE has a market cap of 7.1B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while ESGE trades at $54.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas ESGE's P/E ratio is 18.06. In terms of profitability, JAGLX's ROE is N/A, compared to ESGE's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to ESGE. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check ESGE's competition here
Invesco S&P 500 Low Volatility ETF (AMEX: SPLV)
JAGLX vs SPLV Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, SPLV has a market cap of 7.1B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while SPLV trades at $75.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas SPLV's P/E ratio is 21.57. In terms of profitability, JAGLX's ROE is N/A, compared to SPLV's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to SPLV. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check SPLV's competition here
Vanguard S&P 500 Value ETF (AMEX: VOOV)
JAGLX vs VOOV Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, VOOV has a market cap of 6.9B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while VOOV trades at $228.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VOOV's P/E ratio is 24.01. In terms of profitability, JAGLX's ROE is N/A, compared to VOOV's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VOOV. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VOOV's competition here
T. Rowe Price Global Technology Fund (NASDAQ: PRGTX)
JAGLX vs PRGTX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, PRGTX has a market cap of 6.6B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while PRGTX trades at $36.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas PRGTX's P/E ratio is 49.50. In terms of profitability, JAGLX's ROE is N/A, compared to PRGTX's ROE of +0.14%. Regarding short-term risk, JAGLX is similarly volatile compared to PRGTX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check PRGTX's competition here
Vanguard S&P Small-Cap 600 ETF (AMEX: VIOO)
JAGLX vs VIOO Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, VIOO has a market cap of 6.6B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while VIOO trades at $138.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VIOO's P/E ratio is 19.84. In terms of profitability, JAGLX's ROE is N/A, compared to VIOO's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VIOO. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VIOO's competition here
Capital Group International Focus Equity ETF (AMEX: CGXU)
JAGLX vs CGXU Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, CGXU has a market cap of 6.5B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while CGXU trades at $35.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas CGXU's P/E ratio is 19.29. In terms of profitability, JAGLX's ROE is N/A, compared to CGXU's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to CGXU. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check CGXU's competition here
Vanguard Russell 3000 ETF (NASDAQ: VTHR)
JAGLX vs VTHR Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, VTHR has a market cap of 6.4B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while VTHR trades at $342.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas VTHR's P/E ratio is 27.21. In terms of profitability, JAGLX's ROE is N/A, compared to VTHR's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to VTHR. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check VTHR's competition here
Columbia Global Technology Growth Fund (NASDAQ: CMTFX)
JAGLX vs CMTFX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, CMTFX has a market cap of 6.2B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while CMTFX trades at $141.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas CMTFX's P/E ratio is 37.82. In terms of profitability, JAGLX's ROE is N/A, compared to CMTFX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to CMTFX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check CMTFX's competition here
Vanguard S&P Mid-Cap 400 ETF (AMEX: IVOO)
JAGLX vs IVOO Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, IVOO has a market cap of 6.1B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while IVOO trades at $132.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas IVOO's P/E ratio is 22.98. In terms of profitability, JAGLX's ROE is N/A, compared to IVOO's ROE of +0.00%. Regarding short-term risk, JAGLX is less volatile compared to IVOO. This indicates lower risk in terms of short-term price fluctuations for JAGLX.Check IVOO's competition here
Columbia Global Technology Growth Fund Institutional 2 Class (NASDAQ: CTHRX)
JAGLX vs CTHRX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, CTHRX has a market cap of 6.1B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while CTHRX trades at $145.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas CTHRX's P/E ratio is 37.34. In terms of profitability, JAGLX's ROE is N/A, compared to CTHRX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to CTHRX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check CTHRX's competition here
Janus Henderson Global Life Sciences Fund Class S (NASDAQ: JFNSX)
JAGLX vs JFNSX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, JFNSX has a market cap of 6B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while JFNSX trades at $84.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JFNSX's P/E ratio is N/A. In terms of profitability, JAGLX's ROE is N/A, compared to JFNSX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to JFNSX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check JFNSX's competition here
Janus Henderson Global Life Sciences Fund Class C (NASDAQ: JFNCX)
JAGLX vs JFNCX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, JFNCX has a market cap of 6B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while JFNCX trades at $74.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas JFNCX's P/E ratio is N/A. In terms of profitability, JAGLX's ROE is N/A, compared to JFNCX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to JFNCX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check JFNCX's competition here
Columbia Global Technology Growth Fund (NASDAQ: CTCAX)
JAGLX vs CTCAX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, CTCAX has a market cap of 6B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while CTCAX trades at $133.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas CTCAX's P/E ratio is 37.32. In terms of profitability, JAGLX's ROE is N/A, compared to CTCAX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to CTCAX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check CTCAX's competition here
Columbia Global Technology Growth Fund Class C (NASDAQ: CTHCX)
JAGLX vs CTHCX Comparison August 2026
Janus Henderson Global Life Sciences Fund (NASDAQ: JAGLX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JAGLX stands at 6B. In comparison, CTHCX has a market cap of 6B. Regarding current trading prices, JAGLX is priced at $89.48 on the NASDAQ, while CTHCX trades at $111.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JAGLX currently has a P/E ratio of N/A, whereas CTHCX's P/E ratio is 37.26. In terms of profitability, JAGLX's ROE is N/A, compared to CTHCX's ROE of N/A. Regarding short-term risk, JAGLX is similarly volatile compared to CTHCX. This indicates similar risk in terms of short-term price fluctuations for JAGLX.Check CTHCX's competition here